CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM), announced today that Arthur H. Tinkelenberg, Ph.D., President and Chief Executive Officer, is scheduled to present at the following conferences:
- Biotech Showcase™ 2015 at the Parc 55 Wyndham in San Francisco, on Wednesday, January 14 at 2:30 p.m. PST in Room Mission I.
- Noble Financial Capital Markets’ Eleventh Annual Equity Conference at Club Med Sandpiper Bay in Port St. Lucie, Florida, on Monday, January 19, at 2:30 p.m. EST in Room 1. Dr. Tinkelenberg will also be participating in a panel discussion on immunotherapy, “Changing Paradigm in Cancer Therapy,” on Monday from 5:00 p.m. to 6:30 p.m. in Room 5.
Each of Enumeral’s corporate presentations will be webcast and accessible through Enumeral’s website on the Upcoming Events page. To ensure a timely connection to the webcast, it is recommended that users register at least 10 minutes prior to the scheduled start time. An archived version of the webcast will be available for replay on Enumeral’s website for at least 90 days following the event.
Enumeral is discovering and developing novel antibody immunotherapies that help the immune system attack diseased cells. We believe we have a unique ability to extensively interrogate the human immune microenvironment for candidate selection and validation. We believe our unique capabilities enable us to measure drug effects in a patient-specific manner, providing the basis for developing best-in-class product candidates, based on a fundamental understanding of how immunotherapies work in each patient. We are building a pipeline of immunomodulators for the treatment of cancer and inflammatory diseases and leveraging the breadth of our technology through strategic collaborations. www.enumeral.com